# A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

> **NCT02752087** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY900014

## Key facts

- **NCT ID:** NCT02752087
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02752087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02752087, "A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02752087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*